Alder BioPharmaceuticals (ALDR) named biotech industry veteran Robert Azelby president and CEO of Alder, effective June 13. He also will serve on the company’s board. Azelby joins Alder from Juno Therapeutics (JUNO), where he served as executive vice president and chief commercial officer.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.